Trying to get decent yields with single-agonist peptides can be frustrating, and the triple-target approach basically covers more ground in one go — it’s not for everyone, but most buyers we see in metabolic research move to this after fighting with GLP-1-only results for a while.
You’re looking at a, about 4.1 kDa molecular weight, and it’s soluble in water or buffer solutions without much fuss; we typically stock it at ≥99% purity verified by HPLC, and the 24-month stability (when kept at 2-8°C in dry conditions) gives you breathing room even if your order schedule drifts.
GLP-1, GIP, and glucagon receptor activation is what sets it apart form the usual single-target stuff, but keep in mind it’s not suited for acute dosing studies where you need immediate feedback — the triple mechanism changes kinetics in ways that take longer to plateau, and we’ve seen some researchers prefer the 5mg vial sizes for that reason.
Customiaztion is pretty straightforward through us — our company can do 10mg or 20mg per vial depending on your batch, and the MOQ for non-standerd packaing is 50 units or so (usually 2-4 weeks lead time, but confirm stock before ordering).
What it does is arrive as a fine white lyophilized cake that reconstitutes cleanly, and we always include the COA with each shipment; shippng is typically via cold chain with gel packs, and our company have about 200 vials ready to go in-house right now.